SP Investment Fund LLC is a private company seeking to make a positive impact through strategic investments in worthwhile causes. In addition to investing in efforts to build and preserve affordable housing communities, SP Investment Fund focuses on innovative startups in medical technology. One such startup, Zenflow, aims to revolutionize the treatment of a condition that affects more than 400 million men around the world.
Benign prostatic hyperplasia (BPH), also known as enlargement of the prostate, often causes urinary obstruction. This can lead to a number of complications that can greatly impact the quality of life, such as increased difficulty or frequency of urination and interrupted sleep. Unfortunately, men face limited options for this condition. Drugs developed for the treatment of BPH have limited efficacy, and surgical options are invasive, expensive, and associated with sexual side effects. Zenflow has created an innovative new treatment that offers improved relief from BPH symptoms with fewer side effects. The San Francisco-based startup is pioneering the Spring System, a device that delivers faster relief from BPH symptoms with fewer side effects. Physicians can deploy the device in a single office visit with minimal discomfort for patients and limited risk of complications. Zenflow is testing the Spring System in clinical trials and hopes to release the innovative new treatment soon to the general public.
